Yun Seong Jeong
Overview
Explore the profile of Yun Seong Jeong including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
20
Citations
394
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Yim S, Lee S, Baek S, Sohn B, Jeong Y, Kang S, et al.
Clin Mol Hepatol
. 2025 Feb;
PMID: 40012401
No abstract available.
2.
Yim S, Lee S, Baek S, Sohn B, Jeong Y, Kang S, et al.
Clin Mol Hepatol
. 2024 Jul;
30(4):807-823.
PMID: 39038962
Background/aims: Combination immunotherapy, exemplified by atezolizumab plus bevacizumab, has become the standard of care for inoperable hepatocellular carcinoma (HCC). However, the lack of predictive biomarkers and limited understanding of response...
3.
Jeong Y, Eun Y, Lee S, Kang S, Yim S, Kim E, et al.
Mol Cancer
. 2023 Sep;
22(1):147.
PMID: 37674200
Gastric adenocarcinoma (GAC) is a lethal disease characterized by genomic and clinical heterogeneity. By integrating 8 previously established genomic signatures for GAC subtypes, we identified 6 clinically and molecularly distinct...
4.
Jung J, Park S, Jang Y, Lee S, Jeong Y, Yim S, et al.
Cancers (Basel)
. 2023 Jan;
15(1).
PMID: 36612182
High metabolic activity is a hallmark of cancers, including hepatocellular carcinoma (HCC). However, the molecular features of HCC with high metabolic activity contributing to clinical outcomes and the therapeutic implications...
5.
Lee S, Yim S, Jeong Y, Li Q, Kang S, Sohn B, et al.
Hepatology
. 2022 Mar;
76(6):1634-1648.
PMID: 35349735
Background And Aims: Although many studies revealed transcriptomic subtypes of HCC, concordance of the subtypes are not fully examined. We aim to examine a consensus of transcriptomic subtypes and correlate...
6.
Lee S, Jeong Y, Lee S, Sohn B, Hwang H, Choi G, et al.
Cancer Commun (Lond)
. 2022 Jan;
42(2):179-183.
PMID: 35032367
No abstract available.
7.
Shin M, Kim J, Kim D, Lee S, Shin J, Jeong Y, et al.
Clin Transl Med
. 2021 Jun;
11(6):e421.
PMID: 34185430
No abstract available.
8.
Yim S, Kang S, Shin J, Jeong Y, Sohn B, Um S, et al.
Cells
. 2020 Sep;
9(9).
PMID: 32878261
AT-rich interactive domain 1A () is one of the most frequently mutated genes in hepatocellular carcinoma (HCC), but its clinical significance is not clarified. We aimed to evaluate the clinical...
9.
Rezaeian A, Li C, Wu C, Zhang X, Delacerda J, You M, et al.
Nat Cell Biol
. 2020 Jun;
22(7):907.
PMID: 32504031
An amendment to this paper has been published and can be accessed via a link at the top of the paper.
10.
Yim S, Hae N, Shin J, Jeong Y, Kang S, Park Y, et al.
Exp Mol Pathol
. 2019 Nov;
111:104319.
PMID: 31676327
Introduction: Cirrhosis primes the liver for hepatocellular carcinoma (HCC) development. However, biomarkers that predict HCC in cirrhosis patients are lacking. Thus, we aimed to identify a biomarker directly from protein...